IRCT20151020024625N8已完成2 期
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients with acute myeloid leukemia after chemotherapy
Semnan University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients who went to remission after induction chemotherapy.
排除标准
- •Non remission
- •Sepsis during or after chemotherapy
- •History of hypersensitivity reactions to E. coli-derived proteins and other drugs
研究者
相似试验
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
进行中（未招募）
不适用
Pegfilgrastim versus filgrastim after high-dose chemotherapy followed by autologous peripheral blood stem cell, in patients with hematologic and solid tumors a randomized phase II study - NDPatients with hematological neoplasia or solid tumors treated with high-dose chemotherapyMedDRA version: 6.1Level: HLGTClassification code 10027655EUCTR2006-001409-27-ITISTITUTO CLINICO HUMANITAS80
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
已完成
2 期
Comparison of the effect of two doses of filgrastim in the treatment of neutropeniaIRCT20180103038196N8Gorgan University of Medical Sciences60
进行中（未招募）
不适用
PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.Maintenance of dose-intensityMedDRA version: 6.1Level: HLGTClassification code 10025320EUCTR2005-004646-13-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI50